• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3. 盐酸去氧肾上腺素

3. Phenylephrine hydrochloride.

作者信息

Meyer S M, Fraunfelder F T

出版信息

Ophthalmology. 1980 Nov;87(11):1177-80. doi: 10.1016/s0161-6420(80)35108-7.

DOI:10.1016/s0161-6420(80)35108-7
PMID:7243210
Abstract

Phenylephrine hydrochloride is a potent, effective, relatively safe drug with few ocular side effects. Side effects from topical instillation are uncommon but include severe systemic cardiovascular effects with elevated blood pressure and stroke. Ten percent phenylephrine should be used with caution in patients with known cardiac disease, hypertension, aneurysms, long-standing insulin-dependent diabetes, or advanced arteriosclerosis. A 2.5% concentration is generally indicated for ophthalmic examination as well as for use in infants and in the elderly. Phenylephrine should not be used in patients with narrow-angle glaucoma, and it is also contraindicated in patients taking monoamine oxidase inhibitors or tricyclic antidepressants.

摘要

盐酸去氧肾上腺素是一种强效、有效且相对安全的药物,眼部副作用较少。局部滴注引起的副作用并不常见,但包括严重的全身性心血管效应,如血压升高和中风。已知患有心脏病、高血压、动脉瘤、长期胰岛素依赖型糖尿病或晚期动脉硬化的患者应谨慎使用10%的去氧肾上腺素。2.5%的浓度通常适用于眼科检查以及婴儿和老年人。窄角型青光眼患者不应使用去氧肾上腺素,服用单胺氧化酶抑制剂或三环类抗抑郁药的患者也禁用。

相似文献

1
3. Phenylephrine hydrochloride.3. 盐酸去氧肾上腺素
Ophthalmology. 1980 Nov;87(11):1177-80. doi: 10.1016/s0161-6420(80)35108-7.
2
Possible adverse effects from topical ocular 10% phenylephrine.局部使用10%去氧肾上腺素可能产生的不良反应。
Am J Ophthalmol. 1978 Apr;85(4):447-53. doi: 10.1016/s0002-9394(14)75239-0.
3
[Cardiovascular adverse effects due to phenylephrine eye drops in ophtalmic surgery].[眼科手术中使用去氧肾上腺素滴眼液引起的心血管不良反应]
Ann Fr Anesth Reanim. 2013 Feb;32(2):112-4. doi: 10.1016/j.annfar.2012.12.009. Epub 2013 Jan 30.
4
Systemic reactions to ophthalmic drug preparations.眼科药物制剂的全身反应。
Med Toxicol Adverse Drug Exp. 1987 Jul-Aug;2(4):287-93. doi: 10.1007/BF03259870.
5
Adverse systemic effects from pledgets of topical ocular phenylephrine 10%.
Am J Ophthalmol. 2002 Oct;134(4):624-5. doi: 10.1016/s0002-9394(02)01591-x.
6
Cardiovascular Adverse Effects of Phenylephrine Eyedrops: A Systematic Review and Meta-analysis.苯肾上腺素滴眼液的心血管不良影响:系统评价和荟萃分析。
JAMA Ophthalmol. 2015 Jun;133(6):647-52. doi: 10.1001/jamaophthalmol.2015.0325.
7
Transient ileus associated with the use of mydriatics after screening for retinopathy of prematurity in a very low birth weight infant.在对一名极低出生体重儿进行早产儿视网膜病变筛查后,使用散瞳剂引发的短暂性肠梗阻。
J Pediatr Ophthalmol Strabismus. 2014 Jul 8;51 Online:e44-7. doi: 10.3928/01913913-20140701-02.
8
Systemic effects of topical phenylephrine.局部用去氧肾上腺素的全身效应。
Arch Ophthalmol. 1986 Mar;104(3):336-7. doi: 10.1001/archopht.1986.01050150030012.
9
Acute systemic hypertension after conjunctival instillation of phenylephrine hydrochloride.结膜滴注盐酸去氧肾上腺素后出现急性全身性高血压。
Am J Ophthalmol. 1973 Jul;76(1):156-7. doi: 10.1016/0002-9394(73)90023-8.
10
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: incidence, presentation, and management of complications during general anesthesia.小儿眼科手术患者使用去氧肾上腺素滴眼液:全身麻醉期间并发症的发生率、表现及处理
Paediatr Anaesth. 2014 Apr;24(4):400-5. doi: 10.1111/pan.12329. Epub 2013 Dec 19.

引用本文的文献

1
Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases.眼内混淆因素对视网膜疾病房水蛋白质组学和代谢组学分析的影响。
Transl Vis Sci Technol. 2024 Jun 3;13(6):17. doi: 10.1167/tvst.13.6.17.
2
Pupillary Dilation in Research: More than Meets the Eye.研究中的瞳孔扩张:不止表面所见。
Curr Eye Res. 2022 Jul;47(7):965-977. doi: 10.1080/02713683.2022.2053723. Epub 2022 May 2.
3
Characterizing Current Attitudes and Practices for Human Subject Safety in Studies Involving Pupil Dilation.
描述涉及瞳孔扩张的人体研究中,目前对人体对象安全性的态度和做法。
J Empir Res Hum Res Ethics. 2021 Feb-Apr;16(1-2):54-64. doi: 10.1177/1556264620968989. Epub 2020 Nov 2.
4
Over-the-Counter Ocular Decongestants in the United States - Mechanisms of Action and Clinical Utility for Management of Ocular Redness.美国的非处方眼部减充血剂——眼部发红管理的作用机制与临床应用
Clin Optom (Auckl). 2020 Jul 23;12:95-105. doi: 10.2147/OPTO.S259398. eCollection 2020.
5
Budget impact model of Mydrane®, a new intracameral injectable used for intra-operative mydriasis, from a UK hospital perspective.从英国一家医院的角度看,用于术中散瞳的新型前房内注射药物Mydrane®的预算影响模型。
BMC Ophthalmol. 2018 Apr 19;18(1):104. doi: 10.1186/s12886-018-0746-x.
6
Long Term and Intensive Use of Ophthalmic Topical Corticosteroids and the Risk of Positive Doping Test in Athletes: A Case Report.长期大量使用眼科局部用皮质类固醇与运动员兴奋剂检测呈阳性的风险:一例报告
Asian J Sports Med. 2015 Sep;6(3):e24621. doi: 10.5812/asjsm.24621. Epub 2015 Sep 23.
7
Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions.白内障及人工晶状体手术中瞳孔散大与疼痛的管理:当前药物综述及未来方向
Clin Ophthalmol. 2014 Jul 3;8:1281-9. doi: 10.2147/OPTH.S47569. eCollection 2014.
8
Effective pupil dilatation with a mixture of 0.75% tropicamide and 2.5% phenylephrine: A randomized controlled trial.0.75%托吡卡胺与2.5%去氧肾上腺素混合液有效散瞳:一项随机对照试验。
Indian J Ophthalmol. 2009 Sep-Oct;57(5):351-4. doi: 10.4103/0301-4738.55070.
9
Systemic adverse effects of topical ophthalmic agents. Implications for older patients.局部眼科用药的全身不良反应。对老年患者的影响。
Drugs Aging. 1997 Nov;11(5):352-60. doi: 10.2165/00002512-199711050-00003.
10
Dilate the pupil and see the fundus.散瞳并检查眼底。
Br Med J (Clin Res Ed). 1984 Jun 16;288(6433):1779-80. doi: 10.1136/bmj.288.6433.1779.